Bharat Parenterals Board to Consider Preferential Issue on 29th Sep'26
Bharat Parenterals Ltd 路 Intimation 路 24 Sept 2026, 7:58 pm
Bharat Parenterals Board to Consider Preferential Issue on 29th Sep'26 Bharat Parenterals Limited's Board of Directors is scheduled to meet on 29th Sep'26 to evaluate and approve a proposal for issuing equity shares or other eligible securities via a preferential issue, alongside incidental business matters. Consequently, the trading window for dealing in company securities is closed for designated persons and their immediate relatives with immediate effect from 24th Sep'26, reopening 48 hours after the conclusion of the board meeting.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
